BridgeMD
Prevention study for Fall
Official title The Geriatric Emergency Department Pharmacologic Harm Prevention Project
ClinicalTrials.gov ID: NCT07216846
What this study is testing
- What it's testing
- The goal of this project is to determine whether pharmacogenomic testing (using participants' DNA) can help optimize medication prescribing and reduce side effects in older adults taking five or more medications. The main questions it aims to answer are: Can DNA-based prescribing reduce medication-related side effects, especially falls and fall-related injuries?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 to 110
You may be able to join if
- Patients over the age of 65 with a ground level fall
You likely can't join if
- hospice and/or DNR status.
The study team makes the final eligibility decision.
Where it's taking place
- Delray Beach, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years to 110 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Delray Beach, Florida, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.